Please login or register first to view this content.
Gastrohepatic Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
FDA Grants Orphan Drug Status to Live Biotherapeutic for Pouchitis
FDA Approves Sulfate-Based Tablet Prep for Colonoscopy
Xaracoll Implant Available for Postop Pain After Hernia Surgery
Gimoti Nasal Spray Now Available for Diabetic Gastroparesis
Clinically Meaningful Improvements With Ozanimod in UC Trial
Management of Remdesivir-Associated Acute Liver Failure Examined in Case Series
Fecal Transplant Safe, Effective for C. Difficile Through 6 Months
ACS: Antibiotics Noninferior to Appendectomy for Appendicitis
OTC Medicines Containing “Clean” Inactive Ingredients Launched
Proton Pump Inhibitor Use Linked to Increased Diabetes Risk
Clinical Program for Investigational GERD Drug Discontinued
Prevalence of Adverse Pregnancy Outcomes Assessed With Biologics for IBD
Coffee, Tea, Soda Tied to Higher Risk for Gastroesophageal Reflux
FDA Rejects Terlipressin NDA for Hepatorenal Syndrome Type 1
Dupilumab Gets Breakthrough Therapy Status for Eosinophilic Esophagitis
FDA Fast Tracks SSAO Inhibitor for Nonalcoholic Steatohepatitis
XaraColl Implant Approved for Postop Pain Following Hernia Repair
Postop Nausea, Vomiting Therapy Barhemsys Launched
